Zimmer Biomet director granted 182 phantom stock units

Jafry Syed A. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Jafry Syed A. reported acquisition or exercise transactions in this Form 4 filing.

Zimmer Biomet Holdings director Syed A. Jafry received 182.421 phantom stock units as a compensation award. These units were granted under the Zimmer Biomet Deferred Compensation Plan for Non-Employee Directors and are convertible into an equal number of common shares on a 1-for-1 basis. Following this award, Jafry holds a total of 7,391.591 phantom stock units, which are to be settled in company common stock within sixty days after his service as a director ends.

Insider Trade Summary

Grant/Award: 182.421 shares

Grant/Award 1 txn

Insider Jafry Syed A.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	182.421	$0.00	$0.00

Holdings After Transaction: Phantom Stock Units — 7,391.591 contracts (Direct)

Footnotes (4)

1. F1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
2. F2. The Conversion or Exercise Price of Derivative Security is 1-for-1.
3. F3. Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
4. F4. Includes 18.122 phantom stock units accrued on July 31, 2025, 17.223 phantom stock units accrued on October 31, 2025, and 20.035 phantom stock units accrued January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Key Figures

Phantom units granted: 182.421 units Total phantom units held: 7,391.591 units Conversion ratio: 1-for-1 +1 more

4 metrics

Phantom units granted 182.421 units Grant of phantom stock units on March 31, 2026

Total phantom units held 7,391.591 units Director’s holdings following reported grant

Conversion ratio 1-for-1 Each phantom unit converts into one share of common stock

Dividend reinvestment accruals 55.380 units 18.122 + 17.223 + 20.035 units from 2025–2026 dividend reinvestment

Key Terms

Phantom Stock Units, Deferred Compensation Plan for Non-Employee Directors, dividend reinvestment provision, settled in shares of Company common stock

4 terms

Phantom Stock Units financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Deferred Compensation Plan for Non-Employee Directors financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

dividend reinvestment provision financial

"Includes 18.122 phantom stock units ... under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

A dividend reinvestment provision is a company policy that lets shareholders automatically use their cash dividends to buy more shares instead of receiving money. Think of it like a subscription that turns each payday into buying an extra slice of the same pie; it helps investors compound their holdings over time, often with lower transaction costs and sometimes at a small discount, which can boost long‑term returns and subtly change ownership percentages.

settled in shares of Company common stock financial

"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ZIMMER BIOMET (ZBH) director Syed A. Jafry report on this Form 4?

Director Syed A. Jafry reported receiving 182.421 phantom stock units as a compensation award. These units were granted under Zimmer Biomet’s Deferred Compensation Plan for Non-Employee Directors and convert 1-for-1 into common stock after his board service ends.

How many phantom stock units does Syed A. Jafry hold in ZIMMER BIOMET (ZBH) after this transaction?

After this grant, Syed A. Jafry holds 7,391.591 phantom stock units. These will be settled in shares of Zimmer Biomet common stock within sixty days after his service as a director ceases, reflecting his accumulated deferred director compensation awards.

What are the key terms of the phantom stock units granted to the ZIMMER BIOMET (ZBH) director?

The 182.421 phantom stock units convert into Zimmer Biomet common stock on a 1-for-1 basis. They are issued at a stated price of $0.0000 and will be settled in actual shares within sixty days after the director’s board service ends, per plan terms.

Under which plan were the phantom stock units for ZIMMER BIOMET (ZBH) director granted?

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. This plan allows directors to receive deferred compensation in phantom units that mirror company stock and are later settled in actual common shares.

When will the ZIMMER BIOMET (ZBH) phantom stock units held by the director be settled?

The phantom stock units are scheduled to be settled in shares of Zimmer Biomet common stock within sixty days after the director’s service on the board ends. Settlement timing is therefore tied directly to the cessation of his role as a non-employee director.

What additional phantom stock units were previously accrued for the ZIMMER BIOMET (ZBH) director?

His holdings include 18.122 units from July 31, 2025, 17.223 units from October 31, 2025, and 20.035 units from January 30, 2026. These were accrued under the plan’s dividend reinvestment provision, which credits additional phantom units instead of paying cash dividends.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:20 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jafry Syed A.

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW INDIANA 46580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units(1)	$89.08(2)	03/31/2026		A		182.421		(3)	(3)	Common Stock	182.421	$0	7,391.591(4)	D

Explanation of Responses:

1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

2. The Conversion or Exercise Price of Derivative Security is 1-for-1.

3. Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

4. Includes 18.122 phantom stock units accrued on July 31, 2025, 17.223 phantom stock units accrued on October 31, 2025, and 20.035 phantom stock units accrued January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Syed A. Jafry (power of attorney previously filed)	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)